Beauty Health Co
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.5% | -9.1% | -15.7% | -1.7% | -2.0% | -1.7% | -24.7% | -0.8% | -0.8% | -5.3% | +2.8% | |
| – | -5.4% | -11.9% | -20.4% | -0.9% | -1.6% | -1.6% | -34.8% | +0.7% | +0.4% | -10.3% | +6.3% | |
| – | -6.5% | -15.0% | -21.4% | +2.7% | +3.1% | +0.8% | -43.2% | +3.5% | +6.1% | -12.2% | +0.8% | |
| – | -6.5% | -15.0% | -21.4% | +2.7% | +3.1% | +0.8% | -43.2% | +3.5% | +6.1% | -12.2% | +0.8% | |
| – | -18.8% | -11.2% | -14.4% | -12.3% | -22.4% | -17.3% | +15.3% | -6.4% | -7.7% | -13.6% | -3.1% | |
| – | +22.0% | +4.8% | -19.4% | -4.8% | -5.9% | -5.0% | -9.8% | -5.1% | -14.5% | -0.6% | -1.9% | |
| – | +0.9% | -0.4% | -0.4% | +0.5% | -1.6% | +0.6% | +1.6% | +0.2% | +0.1% | -0.3% | +0.1% | |
| – | -3.9% | -6.0% | -7.3% | -5.9% | -6.8% | -3.9% | -4.7% | -12.7% | -5.8% | -8.3% | -7.9% | |
| – | -1.5% | -10.2% | -17.8% | -0.4% | -0.9% | -1.0% | -30.9% | +1.0% | +0.2% | -4.7% | +3.1% | |
| – | -8.6% | -18.6% | -19.4% | -2.0% | -7.8% | -7.8% | -5.4% | +4.1% | +200.9% | -16.7% | +8.4% | |
| – | -2.4% | +1.1% | -8.0% | +12.8% | +6.6% | -1.4% | +1.8% | -2.4% | +2,460.7% | -17.0% | -0.1% | |
| – | +24.8% | -16.7% | -28.5% | -13.5% | -5.0% | +5.5% | -0.7% | -24.7% | -9.6% | +1.7% | +1.3% | |
| – | +0.1% | -9.9% | -17.3% | +0.1% | +0.1% | +0.1% | -34.3% | +0.1% | -33.8% | +0.4% | +0.3% | |
| – | -34.0% | +6.6% | +9.3% | -13.7% | -13.3% | -11.1% | +60.7% | -11.3% | -7.0% | -9.6% | +0.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.1% | +12.2% | -1.8% | -12.6% | +0.3% | +0.5% | +12.2% | -9.6% | +0.4% | +3.1% | -1.4% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.